HighTide Therapeutics Inc (2511.HK)
HKD 1.11
(14.43%)
HKD 1.11
(14.43%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.02 CNY | -369.77% |
| 2022 | -0.43 CNY | 17.31% |
| 2021 | -0.52 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 HKD | -0.71% |
| 2024 Q1 | -0.00 HKD | 99.96% |
| 2023 Q1 | -0.00 HKD | 99.76% |
| 2023 Q4 | -0.82 HKD | -204900.0% |
| 2023 Q3 | -0.00 HKD | 99.97% |
| 2023 Q2 | -1.21 HKD | -201566.67% |
| 2023 FY | - CNY | -369.77% |
| 2022 Q2 | -0.17 HKD | 0.0% |
| 2022 FY | - CNY | 17.31% |
| 2022 Q4 | -0.25 HKD | 0.0% |
| 2021 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 18298.198% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 112322.222% |